AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (December 14, 2006). doi:10.1152/ajpgi.00528.2006
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
292/4/G1114    most recent
00528.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, Y.
Right arrow Articles by Gonzalez, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, Y.
Right arrow Articles by Gonzalez, F. J.
Submitted on November 11, 2006
Accepted on December 14, 2006

Pregnane X Receptor Activation Ameliorates DSS-Induced IBD Via Inhibition of NF{kappa}B Target Gene Expression

Yatrik Shah1, Xiaochao Ma1, Keiichirou Morimura1, Insook Kim1, and Frank J. Gonzalez2*

1 Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland, United States
2 NIH, United States

* To whom correspondence should be addressed. E-mail: fjgonz{at}helix.nih.gov.

Objectives: Pregnane X receptor expression (PXR) has been shown to be protective in inflammatory bowel disease (IBD) in humans. However, the mechanism by which PXR provides protection remains unclear. Methods: Wild-type and Pxr-null mice were treated with the PXR agonist, pregnenolone-16{alpha}-carbonitrile or vehicle and administered 2.5% dextran sulfate sodium (DSS) in drinking water to induce IBD. Typical clinical symptoms were evaluated on a daily basis. In vivo intestinal permeability assay and proinflammatory cytokine analysis were performed. Results: PXR agonist-treated mice were protected from DSS-induced colitis in comparison to vehicle-treated mice, as defined by body weight loss, diarrhea, rectal bleeding, colon length and histology. Pregnenolone-16{alpha}-carbonitrile did not decrease the severity of IBD in Pxr-null mice. PXR agonist treatment did not increase epithelial barrier function, but did decrease mRNA expression of several NF{kappa}B target genes in a PXR-dependent manner. Conclusions: The present study clearly demonstrates a protective role for PXR agonist in DSS-induced IBD. The data suggest that PXR-mediated repression of NF{kappa}B target genes in the colon is the mechanism by which PXR activation decreases susceptibility of mice to DSS-induced IBD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.